Insmed (INSM) Revenue (2010 - 2026)
Insmed (INSM) reported Revenue of $425.49 million for Q2 2026, up 296.1% from $107.42 million a year earlier and up 39.1% from the prior quarter.
Powered by 
Analysis
Insmed (INSM) Revenue (2010 - 2026) Analysis & Trends
Over the twelve months ended Jun 30, 2026, Insmed's Revenue came in at $1.14 billion, up 185.8% year-over-year; for FY2025, it was $606.42 million, up 66.7% from FY2024.
- Revenue has increased for six consecutive years, with a five-year compound annual growth rate of 29.8% (FY2020 to FY2025).
- By year, Revenue came in at $363.71 million in FY2024 (+19.2%), $305.21 million in FY2023 (+24.4%), $245.36 million in FY2022 (+30.2%) and $188.46 million in FY2021 (+14.6%).
- The Q2 2026 figure ranks as the highest quarterly Revenue in data going back to Q2 2010.
- Year over year, Revenue has now increased in each of the last 22 quarters, with growth averaging 101.9% over the last eight quarters.
- Across the past five years, year-over-year growth in Revenue ran from 5.7% in Q4 2022 to 296.1% in Q2 2026.
- Per Business Quant data, the three quarters before Q2 2026 came in at $305.96 million (Q1 2026), $263.84 million (Q4 2025) and $142.34 million (Q3 2025).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Revenue (Qtr) |
|---|---|---|---|---|---|
| 1 | Johnson & Johnson | 645.01 Bn | 563.54 Bn | 17.26 Bn | 25.31 Bn |
| 2 | AbbVie | 465.23 Bn | 438.39 Bn | 12.70 Bn | 16.99 Bn |
| 3 | Merck | 368.40 Bn | 322.83 Bn | 12.21 Bn | 16.61 Bn |
| 4 | Novartis Ag | 278.02 Bn | 233.89 Bn | 11.24 Bn | 14.41 Bn |
| 5 | Astrazeneca | 254.57 Bn | 228.13 Bn | 12.86 Bn | 15.38 Bn |
| 6 | Amgen | 229.02 Bn | 184.42 Bn | 7.24 Bn | 10.05 Bn |
| 7 | Gilead Sciences | 187.74 Bn | 161.85 Bn | 6.22 Bn | 7.80 Bn |
| 8 | Pfizer | 163.75 Bn | 110.70 Bn | 10.94 Bn | 15.03 Bn |
| 9 | Vertex Pharmaceuticals | 133.45 Bn | 105.45 Bn | 2.84 Bn | 3.33 Bn |
| 10 | Insmed | 25.24 Bn | 19.75 Bn | 358.27 Mn | 425.49 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 425.49 Mn |
| Mar 31, 2026 | 305.96 Mn |
| Dec 31, 2025 | 263.84 Mn |
| Sep 30, 2025 | 142.34 Mn |
| Jun 30, 2025 | 107.42 Mn |
| Mar 31, 2025 | 92.82 Mn |
| Dec 31, 2024 | 104.44 Mn |
| Sep 30, 2024 | 93.43 Mn |
| Jun 30, 2024 | 90.34 Mn |
| Mar 31, 2024 | 75.50 Mn |
| Dec 31, 2023 | 83.69 Mn |
| Sep 30, 2023 | 79.07 Mn |
| Jun 30, 2023 | 77.23 Mn |
| Mar 31, 2023 | 65.21 Mn |
| Dec 31, 2022 | 59.30 Mn |
| Sep 30, 2022 | 67.73 Mn |
| Jun 30, 2022 | 65.22 Mn |
| Mar 31, 2022 | 53.11 Mn |
| Dec 31, 2021 | 56.12 Mn |
| Sep 30, 2021 | 46.76 Mn |
API Access
Insmed Revenue API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=revenue&ticker=INSM&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "revenue", "ticker": "INSM", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=revenue&ticker=INSM&period=max&api_key=YOUR_API_KEY");
const data = await res.json();